Carlos Goycochea, MD
banner
carlosgoycochea.bsky.social
Carlos Goycochea, MD
@carlosgoycochea.bsky.social
IM PGY-3. Dallas Methodist Nephrology Fellow ‘27. POCUS. Informatics. Baseball cards. Husband. Dad. 🇵🇷
I’m going to be a nephrologist!

#fellowmatch #Neph
December 4, 2024 at 5:45 PM
Reposted by Carlos Goycochea, MD
⏩ Join our next #NephJC 👉ADAPT trial, simultaneous publication during #kidneywk

It will be 🍌🍌🍌😉

Effects of dialysate K=3mEq/l with oral SCZ on dialysis-free days vs dialysate K=2.0mEq/l alone on cardiac arrhythmias in pts on HD

www.kidney-international.org/article/S008...
DEFINE_ME
www.kidney-international.org
November 13, 2024 at 6:10 PM
Reposted by Carlos Goycochea, MD
'Effects of sodium–glucose cotransporter 2 inhibitors on cardiovascular and renal outcomes in people with diabetes and advanced chronic kidney disease' 👇👇👇
tinyurl.com/ysd4pr7m
#cardiovascular #cardiovasculardisease #SGLT2i #cardiosky #NephSky
Effects of sodium–glucose cotransporter 2 inhibitors on cardiovascular and renal outcomes in people with diabetes and advanced chronic kidney disease - Diabetologia
Aims/hypothesis Although the benefits of sodium–glucose cotransporter 2 inhibitor (SGLT2i) use in chronic kidney disease (CKD) are well established, the effects of these therapeutic agents in patients...
tinyurl.com
November 16, 2024 at 8:42 AM
Reposted by Carlos Goycochea, MD
Kidney societies and journals, our #CardioSky friends have rapidly mobilized to get started over here. Can #NephSky match their 🦋energy?
November 17, 2024 at 12:58 PM
My first post dedicated to certifying my NRMP rank list for neph fellowship. Can’t wait for Dec/4.
November 17, 2024 at 1:00 PM
Reposted by Carlos Goycochea, MD
This should be sorta interesting from #AHA24 today
The TOPSPIN trial, protocol here: www.sciencedirect.com/science/arti...

Amlodipine + perindopril + indapamide

Low dose single pill combo, this time being tested in India

H/t @anastasiasmihaili.bsky.social
Treatment optimisation for blood pressure with single-pill combinations in India (TOPSPIN) – Protocol design and baseline characteristics
The burden of over 300 million individuals living with hypertension in India is increasing steadily. Most current guidelines recommend initial combina…
www.sciencedirect.com
November 17, 2024 at 12:36 PM